{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T21:06:25Z","timestamp":1709327185441},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"7-8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,22]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Aspirin-exacerbated respiratory disease (AERD) is a triad of asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and adverse respiratory reactions to the ingestion of aspirin\/non-steroidal anti-inflammatory drugs.1 Patients with AERD are frequently plagued with CRSwNP that is difficult to manage with systemic steroids, nasal steroids, and surgical polypectomy, often requiring multiple endoscopic sinus surgeries and frequent otolaryngology follow-up.2,3 There are an abundance of therapies to treat CRSwNP in the setting of AERD, all with varying costs, efficacies, and indications for treatment.4 While limited by side effect profile, aspirin desensitization remains an effective, low-cost treatment for patients with CRSwNP and non-steroidal anti-inflammatory drug sensitivity.5 We describe a case of an active duty U.S. Air Force pilot with AERD whose CRSwNP was successfully treated with aspirin desensitization without detrimental effect on his flying status.<\/jats:p>","DOI":"10.1093\/milmed\/usac344","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T14:34:22Z","timestamp":1668609262000},"page":"e2826-e2828","source":"Crossref","is-referenced-by-count":0,"title":["Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1093","volume":"188","author":[{"given":"Curtis S","family":"Pacheco","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, San Antonio Uniformed Services Health Education Consortium , Fort Sam Houston, TX 78234, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, Wilford Hall Medical Center, 59th Medical Group , Lackland Air Force Base, San Antonio, TX 78236, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M","family":"White","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, Wilford Hall Medical Center, 59th Medical Group , Lackland Air Force Base, San Antonio, TX 78236, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"issue":"4","key":"2023072301111692400_R1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jaip.2018.10.032","article-title":"A one-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease","volume":"7","author":"DeGregorio","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"2023072301111692400_R2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/014556130708600715","article-title":"The prevalence of Samter\u2019s triad in patients undergoing functional endoscopic sinus surgery","volume":"86","author":"Kim","year":"2007","journal-title":"Ear Nose Throat J"},{"issue":"12","key":"2023072301111692400_R3","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1002\/lary.22396","article-title":"Postoperative care for Samter\u2019s triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial","volume":"121","author":"Rotenberg","year":"2011","journal-title":"Laryngoscope"},{"issue":"6","key":"2023072301111692400_R4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2500\/aap.2021.42.210080","article-title":"Treatment options for chronic rhinosinusitis with nasal polyps","volume":"42","author":"Wallace","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"12","key":"2023072301111692400_R5","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/alr.22865","article-title":"Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease","volume":"11","author":"Yong","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"2023072301111692400_R6","article-title":"Medical Standards Directory (MSD)","author":"United States Department of the Air Force","year":"2019"},{"issue":"10209","key":"2023072301111692400_R7","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"2023072301111692400_R8","article-title":"Official Air Force Aerospace Medicine Approved Medications","author":"United States Department of the Air Force","year":"2021"},{"issue":"4","key":"2023072301111692400_R9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/alr.22520","article-title":"Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: a systematic review","volume":"10","author":"Lariv\u00e9e","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"2023072301111692400_R10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2006.06.019","article-title":"Selection of patients for aspirin desensitization treatment","volume":"118","author":"Stevenson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2023072301111692400_R11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.anai.2010.05.020","article-title":"Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease","volume":"105","author":"Lee","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"2023072301111692400_R12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","article-title":"Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily","volume":"63","author":"Rozsasi","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"2023072301111692400_R13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.anai.2020.09.016","article-title":"Local immunoglobulin production in nasal tissues: a key to pathogenesis in CRSwNP and AERD","volume":"126","author":"Buchheit","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"2023072301111692400_R14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2023072301111692400_R15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D2: a dominant mediator of aspirin exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"2023072301111692400_R16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/188\/7-8\/e2826\/50937626\/usac344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/188\/7-8\/e2826\/50937626\/usac344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T01:17:43Z","timestamp":1690075063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/188\/7-8\/e2826\/6825586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":16,"journal-issue":{"issue":"7-8","published-online":{"date-parts":[[2022,11,14]]},"published-print":{"date-parts":[[2023,7,22]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usac344","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,11,14]]}}}